Skip to main content

Aberdeen Group plc

Position in TCRX — TScan Therapeutics, Inc.

CIK 1716774 EDINBURGH, X0

Position in TCRX

as of Mar 31, 2026 · filed Apr 29, 2026
Position Value
$927,200
-$858,041 QoQ
Shares Held
918,020
-48.6% QoQ
Ownership
1.40%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Aberdeen Group plc holds $1,721,223,490 across 84 Biotechnology names. TCRX ranks #78 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TCRX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $927,200 918,020
2025-12-31 $1,785,241 1,785,241
2025-09-30 $2,465,772 1,354,820
2025-06-30 $1,292,599 891,448
2025-03-31 $1,230,198 891,448
2024-12-31 $2,686,460 883,704
2024-09-30 $1,850,841 371,655
2024-06-30 $1,709,042 292,144
2024-03-31 $1,588,000 200,000
2023-12-31 $1,166,000 200,000